The upward revision in both revenue forecast and Adjusted EBITDA for FY24 suggests that Aveanna Healthcare is expecting stronger financial performance than previously anticipated. This positive adjustment is likely to instill confidence among investors, potentially leading to a positive impact on the stock price in the short term. The increase in guidance above both the previous estimates and the market's expectations could be seen as a strong indicator of the company's growth trajectory and operational efficiency improvements.